2016-02-20 - Male - 26 Years old
674451
| Adverse reaction report number | 674451 |
| Latest AER version number | 0 |
| Market authorization holder AER number | N/A |
| Initial received date | 2016-02-20 |
| Latest received date | 2016-02-20 |
| Age | 26 Years |
| Gender | Male |
| Weight | 170 Pounds |
| Type of report | Spontaneous |
| Reporter type | Pharmacist |
| Source of report | Community |
| Report outcome | Recovered/resolved |
| Serious report? | No |
| Product description | Dosage form | Health product role | Route of administration | Dose | Frequency | Therapy duration | Indication(s) |
|---|---|---|---|---|---|---|---|
| ADDERALL XR | CAPSULE, EXTENDED RELEASE | Suspect | Oral | 30 Milligram | 1 every 1 Day(s) | Attention deficit/hyperactivity disorder | |
| ADDERALL XR | CAPSULE, EXTENDED RELEASE | Suspect | Oral | 30 Milligram | 1 every 1 Day(s) | Depression | |
| TACROLIMUS | CAPSULE | Concomitant |
| MedDRA version: v.21.1 | |
| Adverse reaction terms | Reaction duration |
|---|---|
| Condition aggravated | |
| Nicotine dependence | |